Nicole Brufatto, Ph.D. - Publications

2003 Queen's University, Canada, Kingston, Ontario, Canada 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Cochrane A, Murley LL, Gao M, Wong R, Clayton K, Brufatto N, Canadien V, Mamelak D, Chen T, Richards D, Zeghouf M, Greenblatt J, Burks C, Frappier L. Stable complex formation between HIV Rev and the nucleosome assembly protein, NAP1, affects Rev function. Virology. 388: 103-11. PMID 19339032 DOI: 10.1016/j.virol.2009.03.005  0.32
2005 Gao M, Brufatto N, Chen T, Murley LL, Thalakada R, Domagala M, Beattie B, Mamelak D, Athanasopoulos V, Johnson D, McFadden G, Burks C, Frappier L. Expression profiling of herpesvirus and vaccinia virus proteins using a high-throughput baculovirus screening system. Journal of Proteome Research. 4: 2225-35. PMID 16335970 DOI: 10.1021/pr050137u  0.32
2005 Bukys MA, Blum MA, Kim PY, Brufatto N, Nesheim ME, Kalafatis M. Incorporation of factor Va into prothrombinase is required for coordinated cleavage of prothrombin by factor Xa. The Journal of Biological Chemistry. 280: 27393-401. PMID 15897196 DOI: 10.1074/jbc.M503435200  1
2004 Dennis MW, Downey C, Brufatto N, Nesheim ME, Stevenson K, Toh CH. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein Thrombosis and Haemostasis. 91: 522-530. PMID 14983228  0.32
2004 Orfeo T, Brufatto N, Nesheim ME, Xu H, Butenas S, Mann KG. The factor V activation paradox. The Journal of Biological Chemistry. 279: 19580-91. PMID 14982929 DOI: 10.1074/jbc.M400727200  0.32
2004 Schneider M, Brufatto N, Neill E, Nesheim M. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin. The Journal of Biological Chemistry. 279: 13340-5. PMID 14715654 DOI: 10.1074/jbc.M313211200  0.52
2003 Brufatto N, Ward A, Nesheim ME. Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex. Journal of Thrombosis and Haemostasis : Jth. 1: 1258-63. PMID 12871328  1
2003 Brufatto N, Nesheim ME. Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process. The Journal of Biological Chemistry. 278: 6755-64. PMID 12496269 DOI: 10.1074/jbc.M206413200  1
2002 Nesheim M, Samis J, Walker J, Becker L, Brufatto N, Fischer T, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Wenstone R, Downey C, Toh CH. Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients Blood Reviews. 16: S15-22. PMID 12918783  0.32
2002 Toh CH, Samis J, Downey C, Walker J, Becker L, Brufatto N, Tejidor L, Jones G, Houdijk W, Giles A, Koschinsky M, Ticknor LO, Paton R, Wenstone R, Nesheim M. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca ++-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation Blood. 100: 2522-2529. PMID 12239165 DOI: 10.1182/blood.V100.7.2522  0.32
2001 Brufatto N, Nesheim ME. The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation. The Journal of Biological Chemistry. 276: 17663-71. PMID 11278943 DOI: 10.1074/jbc.M011586200  1
Show low-probability matches.